Assay ID | Title | Year | Journal | Article |
AID690938 | Binding affinity to rat KISS1R | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID691442 | Chemical stability of the compound after 30 mins in presence of bovine trypsin at pH 8.5 | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID570385 | Selectivity index, ratio of IC50 for NPFFR1 to IC50 for GPR54 | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID1321541 | Total clearance in Sprague-Dawley rat plasma at 1 mg/kg, iv up to 24 hrs by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID1321525 | Agonist activity at human KISS1R expressed in CHO/dhfr cells assessed as increase in intracellular Ca2+ levels measured for 180 secs by Fluo 3-AM dye based FLIPR assay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID691440 | Agonist activity at human OT7T175 assessed as increase in intracellular calcium level by FLIPR assay | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1820172 | Displacement of [3H]nociceptin from human recombinant NOP receptor expressed in HEK293 cells by scintillation counting analysis | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1321546 | Bioavailability in Sprague-Dawley rat plasma at 1 mg/kg, sc up to 24 hrs by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID570384 | Displacement of (D-[125I]Tyr1, MePhe3)-NPFF from NPFFR2 after 2 hrs | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID570390 | Agonist activity at NPFFR2 expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP accumulation at up to 100 uM after 30 mins | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID347799 | Agonist activity at human GPR54 expressed in CHO cells assessed as effect on kisspeptin-10-induced response by FLIPR assay | 2008 | Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
| Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. |
AID1179681 | Displacement of radioligand from human KISS1R transfected in CHO cells | 2014 | Journal of medicinal chemistry, Jul-24, Volume: 57, Issue:14
| Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity. |
AID1053416 | Plasma concentration in Copenhagen rat at 6 nmol/h, sc measured after 6 days by radioimmunoassay | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID1321528 | Inhibition of testosterone levels in CD(SD) rat assessed as plasma testosterone level <0.04 ng/ml at 0.03 nmol/hr, sc administered continuously for 6 days through alzet osmotic pump measured after 6 days by radio-immunoassay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID690943 | Metabolic stability of the compound in human serum assessed as compound residual ratio after 15 mins | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID1179678 | Agonist activity at human KISS1R transfected in CHO cells assessed as intracellular calcium flux after 24 hrs by functional FLIPR assay | 2014 | Journal of medicinal chemistry, Jul-24, Volume: 57, Issue:14
| Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity. |
AID1321543 | Tmax in Sprague-Dawley rat plasma at 1 mg/kg, sc by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID1321545 | MRT in Sprague-Dawley rat plasma at 1 mg/kg, sc by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID690937 | Binding affinity to human KISS1R | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID347797 | Displacement of [125I]kisspeptin-15 from human GPR54 expressed in CHO cell membrane | 2008 | Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
| Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. |
AID690939 | Metabolic stability of the compound in mouse serum assessed as compound residual ratio at 0.1 mM after 1 hr | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID570386 | Selectivity index, ratio of IC50 for NPFFR2 to IC50 for GPR54 | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID347798 | Ratio of IC50 of compound to IC50 of kisspeptin-10 for human GPR54 | 2008 | Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
| Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. |
AID1820171 | Displacement of [3H]-Diprenorphine from human KOP receptor expressed in HEK293 cells by scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1053426 | Inhibition of human KISS1R expressed in CHO cells assessed as inhibition of KISS1R-mediated cell growth after 4 days by cell counting kit-8 assay | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID1535394 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured immediately by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID1321544 | AUC (0 to 24 hrs) in Sprague-Dawley rat plasma at 1 mg/kg, sc by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID1321542 | Cmax in Sprague-Dawley rat plasma at 1 mg/kg, sc by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID1321540 | Volume of distribution in steady state in Sprague-Dawley rat plasma at 1 mg/kg, iv up to 24 hrs by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID691438 | Drug metabolism in mouse serum assessed as metastin(residue 46 to 54) formation within 1 min by HPLC analysis | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1321539 | AUC (0 to 24 hrs) in Sprague-Dawley rat plasma at 1 mg/kg, iv up to 24 hrs by LC/MS analysis | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID691441 | Ratio of compound EC50 to metastin(residue 45 to 54) EC50 for human OT7T175 | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1535398 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured after 60 mins by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID277660 | Displacement of [125]metastin from metastin receptor | 2007 | Journal of medicinal chemistry, Feb-08, Volume: 50, Issue:3
| Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. |
AID570382 | Displacement of [125I]kisspeptin-15 from GPR54 | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID690941 | Metabolic stability of the compound in human serum assessed as compound residual ratio after 5 mins | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID347805 | Stability in mouse serum within 1 hr | 2008 | Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
| Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. |
AID1179679 | Agonist activity at rat KISS1R transfected in CHO cells assessed as intracellular calcium flux after 24 hrs by functional FLIPR assay | 2014 | Journal of medicinal chemistry, Jul-24, Volume: 57, Issue:14
| Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity. |
AID1179682 | Displacement of radioligand from rat KISS1R transfected in CHO cells | 2014 | Journal of medicinal chemistry, Jul-24, Volume: 57, Issue:14
| Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity. |
AID570389 | Agonist activity at NPFFR1 expressed in HEK293T cells co-expressing Gqi5 assessed as increase of intracellular calcium mobilization at 0.24 uM after 1 hr | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID570395 | Increase of GnRH release in Wistar-imamichi rat median eminence at 0.1 uM after 30 mins by double-antibody radioimmunoassay | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID1053422 | Metabolic stability in mouse serum assessed as compound remaining at 0.1 mM after 1 hr by HPLC analysis | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID1820167 | Displacement of [125I]-Kp-10 from human Kiss1 receptor by TopCount scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1820166 | Displacement of [3H]-PrRP-20 from human PrRP receptor expressed in CHO cells by TopCount scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1535400 | Half life in Sprague-Dawley rat serum at 10 ug/ml by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID690940 | Drug metabolism in mouse plasma at 0.1 mM after 1 min by HPLC-ESI-MS analysis | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID1321529 | Inhibition of testosterone levels in CD(SD) rat assessed as plasma testosterone level <0.04 ng/ml at 0.01 nmol/hr, sc administered continuously for 6 days through alzet osmotic pump measured after 6 days by radio-immunoassay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID690942 | Metabolic stability of the compound in human serum assessed as compound residual ratio after 10 mins | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID1820169 | Displacement of [3H]-Diprenorphine from human MOP receptor expressed in HEK293 cells by scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1053423 | Binding affinity to rat KISS1R | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID570393 | Increase of luteinizing hormone level in Wistar-imamichi rat plasma at 0.25 nmol, administered intracerebroventricularly in preoptic area after 3 hrs measured every 6 mins by double-antibody radioimmunoassay | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID1535397 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured after 30 mins by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID691594 | Half life of the compound in mouse serum | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1053418 | Suppression of testosterone in plasma of Copenhagen rat at 6 nmol/h, sc measured after 6 days by radioimmunoassay | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID1053424 | Binding affinity to human KISS1R expressed in CHO cell membranes | 2013 | Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
| Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity. |
AID1321530 | Inhibition of testosterone levels in CD(SD) rat assessed as plasma testosterone level <0.04 ng/ml at 0.003 nmol/hr, sc administered continuously for 6 days through alzet osmotic pump measured after 6 days by radio-immunoassay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID691439 | Drug metabolism in mouse serum assessed as metastin(residue 46 to 53) formation within 1 min by HPLC analysis | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1535399 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured after 120 mins by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID690936 | Agonist activity at human KISS1R assessed as induction of intracellular calcium mobilization by fluorometric analysis | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID1321526 | Agonist activity at rat KISS1R expressed in CHO/dhfr cells assessed as increase in intracellular Ca2+ levels measured for 180 secs by Fluo 3-AM dye based FLIPR assay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID691437 | Drug metabolism in mouse serum within 1 min by HPLC analysis | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Trypsin resistance of a decapeptide KISS1R agonist containing an Nω-methylarginine substitution. |
AID1321527 | Inhibition of testosterone levels in CD(SD) rat assessed as plasma testosterone level <0.04 ng/ml at 0.1 nmol/hr, sc administered continuously for 6 days through alzet osmotic pump measured after 6 days by radio-immunoassay | 2016 | Journal of medicinal chemistry, 10-13, Volume: 59, Issue:19
| Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH |
AID1535395 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured after 5 mins by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID1820170 | Displacement of [3H]-Diprenorphine from human DOP receptor expressed in HEK293 cells by scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID690944 | Half life in human serum | 2012 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 22, Issue:20
| Serum stability of selected decapeptide agonists of KISS1R using pseudopeptides. |
AID1535393 | Agonist activity at human KISS1R expressed in CHO cells assessed as increase in calcium mobilization measured at 2 secs interval for 2 mins by fluo-4 NW dye based FLIPR assay | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID277661 | Activity at metastin receptor expressed in HEK293 cells by measuring calcium release | 2007 | Journal of medicinal chemistry, Feb-08, Volume: 50, Issue:3
| Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. |
AID570391 | Agonist activity at NPFFR1 expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP accumulation at up to 100 uM after 30 mins | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID570383 | Displacement of (D-[125I]Tyr1, MePhe3)-NPFF from NPFFR1 after 2 hrs | 2011 | ACS medicinal chemistry letters, Jan-13, Volume: 2, Issue:1
| Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands. |
AID1535396 | Stability in Sprague-Dawley rat serum assessed as parent compound remaining at 10 ug/ml measured after 15 mins by LC-MS/MS analysis | 2019 | Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
| A new class of pentapeptide KISS1 receptor agonists with hypothalamic-pituitary-gonadal axis activation. |
AID1820168 | Displacement of [125I]-43RFa from human QRFP receptor expressed in CHO cells by TopCount scintillation counting method | 2021 | Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
| Identification of an |
AID1798671 | Receptor Binding Assay from Article 10.1021/jm800930w: \\Development of Novel G-Protein-Coupled Receptor 54 Agonists with Resistance to Degradation by Matrix Metalloproteinase.\\ | 2008 | Journal of medicinal chemistry, Dec-11, Volume: 51, Issue:23
| Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. |
AID1346040 | Human kisspeptin receptor (Kisspeptin receptor) | 2001 | The Journal of biological chemistry, Sep-14, Volume: 276, Issue:37
| The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. |
AID1346989 | Rat kisspeptin receptor (Kisspeptin receptor) | 2001 | The Journal of biological chemistry, Sep-14, Volume: 276, Issue:37
| The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. |
AID1346040 | Human kisspeptin receptor (Kisspeptin receptor) | 2001 | Nature, May-31, Volume: 411, Issue:6837
| Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |